Capula Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,670	Closed	-$293K	–	251
2025 Q1	$293K	Buy	+17,670	New	+$293K	﹤0.01%	192
2021 Q3	–	Sell	-15,012	Closed	-$366K	–	495
2021 Q2	$366K	Buy	+15,012	New	+$366K	0.01%	216